Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share (Details)

v3.5.0.2
Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Basic and diluted numerator:    
Net loss available to iBio, Inc. stockholders $ (3,061) $ (1,805)
Basic and diluted denominator:    
Weighted-average common shares outstanding 89,109 77,307
Per Share Amount $ (0.03) $ (0.02)